Respiratory Syncytial Virus, or RSV, can behave like a cold. But if you’re 65+, it can lead to life-threatening conditions

Severe conditions like pneumonia and trouble breathing can occur in 65+ who get infected with RSV. Nearly 200,000 elderly people are hospitalized with the virus every year.

Young children are also at high risk for serious complications.

Underlying heart or lung conditions, a weakened immune system, COPD, or asthma can worsen the outcome for those who get infected with RSV.

There’s no vaccine for RSV—yet. You can help change that. Please consider participating in RSV vaccine clinical trials. Your participation could protect you and those you love against RSV, now and in the future.

Take the next step to see if you qualify for local RSV vaccine studies. But don’t delay — space is limited!

Get started now

How does it work?

1

Tell us a little bit about yourself

2

Answer some questions about your health

3

We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exams rooms thoroughly between every patient visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.